Insiders · MMSI

Joseph Wright

Chief Commercial Officer at Merit Medical Systems Inc (MMSI)

Joseph Wright has filed 12 insider reports with the SEC since March 2021, as chief Commercial Officer at Merit Medical Systems Inc (MMSI). Joseph Wright made no open-market purchases or sales in the last 12 months. In the latest filing, on March 8, 2024, Joseph Wright sold 25,000 shares of Merit Medical Systems Inc (MMSI) for $1.89M at an average of $75.68.

Filings
12
Companies
1
Bought on market
None
Sold on market
$4.5M

Companies where Joseph Wright is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
MMSI Merit Medical Systems IncChief Commercial Officer42,223$4.5M$88.42Mar 8, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Joseph Wright with

Other insiders at the same companies

Questions about Joseph Wright

What is Joseph Wright's role at Merit Medical Systems Inc?
Joseph Wright reports to the SEC as chief Commercial Officer at Merit Medical Systems Inc (MMSI), according to the latest filing on March 8, 2024.
How many shares does Joseph Wright own?
After the latest filing that states it, Joseph Wright directly owned 42,223 shares of Merit Medical Systems Inc (MMSI). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Joseph Wright bought or sold stock recently?
The most recent open-market sale was on March 7, 2024: sold 25,000 shares of Merit Medical Systems Inc (MMSI) for $1.89M at an average of $75.68.
How do I get alerts when Joseph Wright files?
Follow Joseph Wright on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Joseph Wright (SEC CIK 0001643713). Totals count each trade once, skipping amendments whose original is on file, from Mar 2, 2021 on. View on SEC EDGAR